Esperion Therapeutics Inc (ESPR)

[Stockstuffer83]

This big picture is the statins are now mostly patent expired. Now pharma is looking for a new oral branded drug to make up for that.

Additionally, if this drug can lower ldl and increase hdl similarly to statins which fish oils cannot decrease ldl significantly (fish oil is best for hdl increases) then it can become the first line over statins or be pushed to use in combo with statins as initial therapy it will greatly increase the value of this drug.

Lipid panels are complex and confusing. Ldl is always your primary goal assuming triglycerides are not super high. Then comes hdl as a priority.